Actionable news
All posts from Actionable news
Actionable news in MDXG: MiMedx Group, Inc,

Canaccord Maintains Buy on MiMedx Group Inc Following Analyst Day

In a research note issued today, Canaccord analyst William Plovanic maintained a Buy rating on shares of MiMedx Group Inc (NASDAQ:MDXG), with a price target of $14, after the company hosted its annual analyst day yesterday in New York City. MiMedx shares are currently trading at $8.01, down $0.43 or 5.09 percent.

Plovanic noted, “MiMedx outlined the broad product portfolio that now includes amniotic tissue, amniotic fluid, and collagen technology based products. We heard from practicing physicians and management on the broad applicability of the technologies, as well as numerous clinical studies and case...